Product
VER-01
Aliases
trans-Δ9-Tetra-hydrocannabinol (THC)
4 clinical trials
2 indications
Indication
Chronic Non-specific Low Back PainIndication
HealthyClinical trial
Proof of Efficacy, Maintenance of Efficacy, Long-term Safety and Investigation of the Potential for Dependence and Abuse and the Effect of Abrupt Drug Withdrawal of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back PainStatus: Completed, Estimated PCD: 2024-03-26
Clinical trial
Multicentre, Randomized, Open-label Study to Prove an Additional Benefit of the Full-spectrum Cannabis Extract VER-01 Over Opioids in the Treatment of Patients With Chronic Non-specific Low Back PainStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Clinical trial
Randomized Open-label Study to Evaluate the Pharmacokinetics and Safety of VER-01 After Single Dose With and Without Meal in Healthy VolunteersStatus: Completed, Estimated PCD: 2022-11-17
Clinical trial
Multicenter, Double-blind, Randomized, Placebo-controlled, Dose Response Trial With the Full-spectrum Cannabis Extract VER-01 in Patients With Chronic Non-specific Low Back PainStatus: Not yet recruiting, Estimated PCD: 2025-07-01